Examining the Effectiveness and Duration of Adjuvanted Vs. Non-Adjuvanted Influenza Vaccines in Protecting Older Adults Against Symptomatic SARS-CoV-2 Infection
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY（2024）
Key words
COVID-19,cross-protection,influenza vaccine,older adults,primary care
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined